Announcements Trials

Browse Landscape

Phase

Phase 2 9 Phase 1 3 Phase 4 1 Phase 3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 9 Head and Neck Neoplasms 4 Small Cell Lung Carcinoma 3 Lymphoma, Extranodal NK-T-Cell 2 Esophageal Squamous Cell Carcinoma 2 Esophageal Neoplasms 2 Uterine Cervical Neoplasms 1 Squamous Non-small-cell Lung Cancer 1 Squamous Cell Carcinoma of Head and Neck 1 Non-Small Cell Lung Cancer Metastatic 1 Neuroendocrine Tumors 1 Neoplasm Metastasis 1 Nasopharyngeal Neoplasms 1 Melanoma 1 Medulloblastoma 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, Mantle-Cell 1 Lymphohistiocytosis, Hemophagocytic 1 Lung Neoplasms 1 Locally Advanced Malignant Neoplasm 1 Intracranial Germ Cell Tumors 1 Carcinoma, Squamous Cell 1 Cancer Therapy-related Cardiovascular Toxicity 1 Anemia 1 Adenocarcinoma of Lung 1

Interventions

Cyclophosphamide 2 temsirolimus 1 prednylidene 1 ibrutinib 1 acalabrutinib 1 Vincristine 1 Thiotepa 1 Thalidomide 1 Rituximab 1 Radiotherapy 1 Prednisone 1 Filgrastim 1 Etoposide 1 Doxorubicin 1 Dexamethasone 1 Cytarabine 1 Cisplatin 1 Antilymphocyte Serum 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Lymphoma, Mantle-Cell × Cisplatin × Clear all

NCT02858804 2026-02-11

BDH-MCL01

Institute of Hematology & Blood Diseases Hospital, China

Phase 4 Completed

Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡